Literature DB >> 8395085

Late development of cholangiocarcinoma after the treatment of hepatolithiasis.

K Chijiiwa1, H Ichimiya, S Kuroki, A Koga, F Nakayama.   

Abstract

Although the association of cholangiocarcinoma with intrahepatic calculi (hepatolithiasis) is well recognized, the late development of cholangiocarcinoma after the treatment of hepatolithiasis has not been reported in detail. Of 109 consecutive patients with hepatolithiasis treated during 19 years, eight patients had cholangiocarcinoma, seven of whom had cholangiocarcinoma two to 14 years, with a mean of eight years, after the treatment of hepatolithiasis. Absence of cholangiocarcinoma was confirmed when stones were removed at the time of the initial treatment. The mean age was 56 years, with a female to male ratio of 2:5. At the time of detecting cholangiocarcinoma, three patients had no gallstones and four had gallstones at the corresponding site to the carcinoma. Cystic dilatation of the intrahepatic bile duct was often observed on the direct cholangiogram. The biles were all infected mainly with Escherichia coli and Klebsiella species. Thus, bile stasis and bacteria infection seems to be the important causative factor, causing cholangiocarcinoma rather than the calculi itself. Because the symptoms only mimic those of cholangitis, the possible presence of cholangiocarcinoma should be considered even after the treatment of hepatolithiasis for early detection and curative resection.

Entities:  

Mesh:

Year:  1993        PMID: 8395085

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  15 in total

1.  New development of biliary surgery in China.

Authors:  Qiang-Huang Zhi
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 2.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

3.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

4.  Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma.

Authors:  Qian D Zhu; Meng T Zhou; Qing Q Zhou; Hong Q Shi; Qi Y Zhang; Zheng P Yu
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

5.  Treatment of non-endemic hepatolithiasis in a Western country. The role of hepatic resection.

Authors:  Marco Catena; Luca Aldrighetti; Renato Finazzi; Giandomenico Arzu; Marcella Arru; Carlo Pulitanò; Gianfranco Ferla
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

Review 6.  The treatment of gall stones.

Authors:  N Tait; J M Little
Journal:  BMJ       Date:  1995-07-08

7.  Intrahepatic stones. The transhepatic team approach.

Authors:  H A Pitt; A C Venbrux; J Coleman; C A Prescott; M S Johnson; F A Osterman; J L Cameron
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

8.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.

Authors:  Hyo Jung Kim; Jae Seon Kim; Sang Jun Suh; Beom Jae Lee; Jong-Jae Park; Hong Sik Lee; Chang Duck Kim; Young-Tae Bak
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

9.  A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort.

Authors:  Yutaka Suzuki; Toshiyuki Mori; Masaaki Yokoyama; Sangchul Kim; Hirokazu Momose; Ryota Matsuki; Masaharu Kogure; Nobutsugu Abe; Hiroyuki Isayama; Takahiro Nakazawa; Kenji Notohara; Atsushi Tanaka; Toshio Tsuyuguchi; Susumu Tazuma; Hajime Takikawa; Masanori Sugiyama
Journal:  J Gastroenterol       Date:  2017-11-08       Impact factor: 7.527

Review 10.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.